SABS insider filings

SAB Biotherapeutics, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-09-18. Screen SABS transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 1 insider filing (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Kropotova Alexandra — CHIEF MEDICAL OFFICER1——1

Recent insider filings — SAB Biotherapeutics, Inc.

FiledFormInsiderReported transactionsSource
2026-09-184Kropotova Alexandra — CHIEF MEDICAL OFFICERTax withholding (F): 473EDGAR
2026-06-264Kropotova Alexandra — CHIEF MEDICAL OFFICERTax withholding (F): 988EDGAR
2026-03-254Kropotova Alexandra — CHIEF MEDICAL OFFICERTax withholding (F): 988EDGAR
2026-02-054Sullivan Eddie Joe — PRESIDENT, DirectorGrant/award (A): 3,000,000 (derivative) @ $0EDGAR
2026-02-054Bausch Christoph Lawrence — CHIEF OPERATING OFFICERGrant/award (A): 1,800,000 (derivative) @ $0EDGAR
2026-02-054To Lucy — See RemarksGrant/award (A): 2,400,000 (derivative) @ $0EDGAR
2026-02-054Kropotova Alexandra — CHIEF MEDICAL OFFICERGrant/award (A): 2,400,000 (derivative) @ $0EDGAR
2026-02-054Reich Samuel J — CEO, DirectorGrant/award (A): 4,800,000 (derivative) @ $0EDGAR
2026-01-074Jain Rita — DirectorGrant/award (A): 240,000 (derivative) @ $0EDGAR
2026-01-074ZACCARDELLI DAVID — DirectorGrant/award (A): 240,000 (derivative) @ $0EDGAR
2025-12-184Polvino William James — DirectorGrant/award (A): 150,000 (derivative) @ $0EDGAR
2025-12-184Ellias Helen K. — DirectorGrant/award (A): 150,000 (derivative) @ $0EDGAR
2025-12-184Giberson Scott — DirectorGrant/award (A): 150,000 (derivative) @ $0EDGAR
2025-12-184Link David — DirectorGrant/award (A): 150,000 (derivative) @ $0EDGAR
2025-12-184Lucera Erick — DirectorGrant/award (A): 150,000 (derivative) @ $0EDGAR
2025-12-184SKYLER JAY S — DirectorGrant/award (A): 150,000 (derivative) @ $0EDGAR
2025-12-124Kropotova Alexandra — CHIEF MEDICAL OFFICERTax withholding (F): 988EDGAR
2025-10-014Moin Andrew — DirectorOption exercise (M): 1,740,000 @ $1.75 · Option exercise (M): 17,400 (derivative)EDGAR
2025-10-014Sessa Capital (Master), L.P. — Director
Sessa Capital GP, LLC — Director
Sessa Capital IM, L.P. — Director
Sessa Capital IM GP, LLC — Director
Petry John — Director
Option exercise (M): 1,740,000 @ $1.75 · Option exercise (M): 17,400 (derivative)EDGAR
2025-09-224Kropotova Alexandra — CHIEF MEDICAL OFFICERTax withholding (F): 1,977EDGAR
2025-08-284To Lucy — See RemarksGrant/award (A): 1,200,000 (derivative) @ $0EDGAR
2025-08-284Bausch Christoph Lawrence — CHIEF OPERATING OFFICERGrant/award (A): 600,000 (derivative) @ $0EDGAR
2025-08-284Sullivan Eddie Joe — PRESIDENT, DirectorGrant/award (A): 3,000,000 (derivative) @ $0EDGAR
2025-08-284Kropotova Alexandra — CHIEF MEDICAL OFFICERGrant/award (A): 2,400,000 (derivative) @ $0EDGAR
2025-08-284Reich Samuel J — CEO & EXECUTIVE CHAIRMAN, DirectorGrant/award (A): 4,800,000 (derivative) @ $0EDGAR
2025-07-244Moin Andrew — DirectorGrant/award (A): 228,500 (derivative) · Grant/award (A): 228,500 (derivative) · Grant/award (A): 114,250 (derivative)EDGAR
2025-07-244Sessa Capital (Master), L.P. — Director
Sessa Capital GP, LLC — Director
Sessa Capital IM, L.P. — Director
Sessa Capital IM GP, LLC — Director
Petry John — Director
Grant/award (A): 228,500 (derivative) · Grant/award (A): 228,500 (derivative) · Grant/award (A): 114,250 (derivative)EDGAR
2025-04-014Kropotova Alexandra — CHIEF MEDICAL OFFICERTax withholding (F): 1,179EDGAR
2024-12-314Kropotova Alexandra — CHIEF MEDICAL OFFICERTax withholding (F): 9,072EDGAR
2024-11-054Ellias Helen K. — DirectorGrant/award (A): 20,000 (derivative) @ $0 · Grant/award (A): 35,000 (derivative) @ $0EDGAR
2024-08-134To Lucy — See RemarksGrant/award (A): 125,000 (derivative) @ $0EDGAR
2024-07-174Link David Charles — DirectorGrant/award (A): 20,000 (derivative) @ $0 · Grant/award (A): 9,305 (derivative) @ $0EDGAR
2024-07-174Polvino William James — DirectorGrant/award (A): 20,000 (derivative) @ $0 · Grant/award (A): 13,958 (derivative) @ $0EDGAR
2024-07-174Sullivan Eddie Joe — PRESIDENT, DirectorGrant/award (A): 46,528 (derivative) @ $0 · Grant/award (A): 4,447 (derivative) @ $0EDGAR
2024-07-174Giberson Scott — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2024-07-174Lucera Erick — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2024-07-174Spragens Jeffrey G — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2024-07-174Reich Samuel J — CEO & EXECUTIVE CHAIRMAN, DirectorGrant/award (A): 35,700 (derivative) @ $0EDGAR
2024-07-174SKYLER JAY S — DirectorGrant/award (A): 20,000 (derivative) @ $0 · Grant/award (A): 35,000 (derivative) @ $0EDGAR
2024-07-174HAMILTON CHRISTINE E — DirectorGrant/award (A): 20,000 (derivative) @ $0 · Grant/award (A): 5,815 (derivative) @ $0 · Grant/award (A): 4,447 (derivative) @ $0 · Grant/award (A): 44,202 (derivative) @ $0 · Grant/award (A): 2,326 (derivative) @ $0EDGAR
2024-02-234Sullivan Eddie Joe — PRESIDENT, DirectorGrant/award (A): 190,000 (derivative) @ $0EDGAR
2024-02-234Bausch Christoph Lawrence — CHIEF OPERATING OFFICERGrant/award (A): 140,000 (derivative) @ $0EDGAR
2024-02-234King Michael — CHIEF FINANCIAL OFFICERGrant/award (A): 115,000 (derivative) @ $0EDGAR
2024-02-234Kropotova Alexandra — CHIEF MEDICAL OFFICERGrant/award (A): 140,000 (derivative) @ $0EDGAR
2024-02-234Reich Samuel J — CEO & EXECUTIVE CHAIRMAN, DirectorGrant/award (A): 434,000 (derivative) @ $0EDGAR
2023-12-084Sullivan Eddie Joe — Chief Executive Officer, DirectorPurchase (P): 1,740 @ $0.88EDGAR
2023-11-304King Michael — CHIEF FINANCIAL OFFICERPurchase (P): 5,000 @ $0.90EDGAR
2023-11-304Reich Samuel J — Executive Chairman, DirectorPurchase (P): 11,000 @ $0.89EDGAR
2023-11-284Ellias Helen K. — DirectorOption exercise (M): 2,857,142 · Option exercise (M): 1,800 (derivative) @ $1,000EDGAR
2023-11-284Sessa Capital (Master), L.P. — Director
Sessa Capital GP, LLC — Director
Sessa Capital IM, L.P. — Director
Sessa Capital IM GP, LLC — Director
Petry John — Director
Option exercise (M): 4,584,571 · Option exercise (M): 31,269 (derivative) @ $1,000 · Option exercise (M): 28,380 (derivative) @ $1,000EDGAR

Recent 8-K events — SAB Biotherapeutics, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-10-138-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-078-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-188-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-05-048-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-228-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-198-K1.01 — Entry into a Material Definitive Agreement
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-108-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-128-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-078-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2025-12-298-K8.01 — Other EventsEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=SABS returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs